What smart money is saying about Telix Pharmaceuticals
No fund has written a full thesis on Telix Pharmaceuticals in our archive, but 2 fund letters report a position in it, most recently Glennon Small Companies Limited in September 2026.
Get an email when a fund buys, sells or pitches it
Position history
Every position in Telix Pharmaceuticals on record in the archive was reported in Q3 2026, across 2 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 2 positions
- HoldsGlennon Small Companies LimitedSeptember 2026
“Telix Pharmaceuticals ASX: TLX Telix Pharmaceuticals is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals.”
Telix Pharmaceuticals - HoldsGlennon Capital Small Companies PortfolioSeptember 2026
“Telix Pharmaceuticals ASX: TLX Telix Pharmaceuticals is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals.”
Telix Pharmaceuticals
Also mentioned · 1
These funds discuss Telix Pharmaceuticals as a competitor, benchmark or comparable, without disclosing a position in it.
- MentionedPaladin ONESeptember 2026
“The high willingness to pay for isotope manufacturers is shown by the takeover of the Munich radiopharma company ITM by the Australian biopharma company Telix, agreed in September.”
Telix Pharmaceuticals
Read the letters behind these Telix Pharmaceuticals positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→